Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 159 entries
View as:

Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648856 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650234 Org: User:
Start: 02/29/04 End: 03/31/04 Due: 03/31/05

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649402 Org: User:
Start: 05/31/04 End: 06/30/04 Due: 06/30/05

Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647972 Org: User:
Start: 05/31/03 End: - Due: -

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648219 Org: User:
Start: 12/31/05 End: 01/31/06 Due: 01/31/07

Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648271 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650052 Org: User:
Start: 11/30/03 End: 12/31/03 Due: 12/31/04

Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649168 Org: User:
Start: 04/30/07 End: 06/30/07 Due: 06/30/08

Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649116 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Phase: N/A Priority: Normal
NCT ID: NCT00648128 Org: User:
Start: 03/31/03 End: 03/31/03 Due: 03/31/04

Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649103 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648570 Org: User:
Start: 08/31/04 End: 10/31/04 Due: 10/31/05

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650299 Org: User:
Start: 08/31/04 End: 08/31/04 Due: 08/31/05

Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648518 Org: User:
Start: 12/31/03 End: 12/31/03 Due: 12/31/04

Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649454 Org: User:
Start: 06/30/05 End: 06/30/05 Due: 06/30/06

Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650364 Org: User:
Start: 08/31/02 End: 09/30/02 Due: 09/30/03

Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649051 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650312 Org: User:
Start: 10/31/02 End: 11/30/02 Due: 11/30/03

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg

Phase: N/A Priority: Normal
NCT ID: NCT00647855 Org: User:
Start: 05/31/03 End: 06/30/03 Due: 06/30/04

Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648531 Org: User:
Start: 05/31/04 End: 05/31/04 Due: 05/31/05

Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647621 Org: User:
Start: 10/31/05 End: 12/31/05 Due: 12/31/06

Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650533 Org: User:
Start: 11/30/04 End: 12/31/04 Due: 12/31/05

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649558 Org: User:
Start: 02/28/03 End: 03/31/03 Due: 03/31/04

Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650195 Org: User:
Start: 02/29/04 End: 03/31/04 Due: 03/31/05

Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648401 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07